Cargando…
Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design
Inhibition of aromatase (CYTP450) as a key enzyme in the estrogen biosynthesis could result in regression of estrogen-dependent tumors and even preventing the promotion of breast cancer. Although today potent steroid and non-steroid inhibitors of aromatase are available, isoflavanone derivatives as...
Autores principales: | Mirzaie, Sako, Chupani, Latifeh, Asadabadi, Ebrahim Barzegari, Shahverdi, Ahmad Reza, Jamalan, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531781/ https://www.ncbi.nlm.nih.gov/pubmed/26417225 |
Ejemplares similares
-
Development a novel multiepitope DNA vaccine against human SARS coronavirus-2: an immunoinformatic designing study
por: NEMATI, Afshin Samimi, et al.
Publicado: (2022) -
Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors
por: Mirzaie, Sako, et al.
Publicado: (2013) -
Predictions of Protein-Protein Interfaces within Membrane Protein Complexes
por: Asadabadi, Ebrahim Barzegari, et al.
Publicado: (2013) -
Sulfonanilide Derivatives in Identifying Novel Aromatase Inhibitors by Applying Docking, Virtual Screening, and MD Simulations Studies
por: Rampogu, Shailima, et al.
Publicado: (2017) -
Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme
por: Adon, Tenzin, et al.
Publicado: (2023)